[Update on Pulmonary Embolism: Guideline-Based Diagnosis and Therapy of an Exemplary Case].
Kerstin A SchürchErik W HolyNils KucherAlexandru GrigoreanPublished in: Praxis (2022)
Update on Pulmonary Embolism: Guideline-Based Diagnosis and Therapy of an Exemplary Case Abstract. In the evaluation of acute pulmonary embolism, a swift and focused diagnostic process is crucial and has an impact on prognosis. An initial clinical assessment is done in haemodynamically stable patients, followed by determination of D-dimer or immediate imaging by computer tomography if the clinical (pre-test) probability is high. After confirming the diagnosis of pulmonary embolism, the most appropriate anticoagulant regiment should be selected and patients should be candidate for a structured follow-up plan. The initial anticoagulant therapy regime is determined by a number of factors, including haemodynamic stability (or potential need for reperfusion treatments), demographic characteristics and comorbidities. While anticoagulation is usually recommended for the first 3-6 months, re-evaluation of therapy after acute therapy is mandatory. In addition, the possibility of chronic thrombo-embolic pulmonary hypertension (CTEPH) or a post-PE syndrome should be considered if symptoms persist after 3-6 months.
Keyphrases
- pulmonary embolism
- inferior vena cava
- pulmonary hypertension
- atrial fibrillation
- ejection fraction
- newly diagnosed
- venous thromboembolism
- heart failure
- prognostic factors
- high resolution
- acute myocardial infarction
- mass spectrometry
- depressive symptoms
- liver failure
- physical activity
- percutaneous coronary intervention
- mesenchymal stem cells
- machine learning
- cell therapy
- drug induced
- patient reported outcomes
- photodynamic therapy
- molecularly imprinted
- pulmonary artery
- left ventricular
- replacement therapy
- sleep quality
- subarachnoid hemorrhage